Science is big business, as Relx can testify. The former Reed Elsevier reported yesterday that pay-to-publish was growing “particularly strongly”after the company published more than 150,000 articles last year on that basis, 26 per cent more than in 2021.
This is only a small part of Relx’s scientific, technical and medical (STM) division, which accounts for just a third of the group’s overall revenues. But it shows how the company’s modern cloud-based garb, distributing and analysing ever-increasing shoals of data, has roots in traditional publishing.
The stock market took in its stride a third-quarter trading update showing underlying revenue growth of 8 per cent in the first nine months of the year, with the expectation that revenue and adjusted operating profit will remain above trend,
